Group B streptococcal necrotizing pneumonia in a diabetic adult patient

Rev Argent Microbiol. 2017 Apr-Jun;49(2):139-141. doi: 10.1016/j.ram.2016.09.005. Epub 2017 Mar 18.

Abstract

The aim of this report is to describe a rare case of necrotizing pneumonia due to group B Streptococcus serotype III in a relatively young male adult (48 years old) suffering from diabetes. The organism was isolated from his pleural fluid and was only resistant to tetracycline. The patient first received ceftazidime (2g/8h i.v.)+clindamycin (300mg/8h) for 18 days and then he was discharged home and orally treated with amoxicillin clavulanic acid (1g/12h) for 23 days with an uneventful evolution. As in the cases of invasive infection by Streptococcus pyogenes, clindamycin could prevent streptococcal toxic shock syndrome.

Keywords: Diabetes; Group B Streptococcus; Necrotizing pneumonia; Neumonía necrosante; Streptococcus del grupo B.

Publication types

  • Case Reports

MeSH terms

  • Clindamycin
  • Diabetes Complications*
  • Diabetes Mellitus
  • Humans
  • Male
  • Middle Aged
  • Pneumonia, Necrotizing* / complications
  • Pneumonia, Necrotizing* / diagnosis
  • Pneumonia, Necrotizing* / microbiology
  • Streptococcal Infections* / complications
  • Streptococcal Infections* / diagnosis
  • Streptococcus pyogenes

Substances

  • Clindamycin